TMDX
TransMedics Group, Inc.$88.34+2.49 (+2.90%)Prev Close$85.86·MCap$3.11B·P/E20.22·Vol701.0K·Yield—
▲
Buys (12M)
1
$109.1K
▼
Sells (12M)
3
$1.43M
◆
Net Activity
Net Seller
$1.32M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at TransMedics Group, Inc. (TMDX) has been dominated by selling, with 1 insider purchase totaling $109.1K and 3 insider sales totaling $1.43M. The most recent insider transaction was by Weill David (director), who purchased $109.1K worth of shares on Sep 14, 2026. TransMedics Group, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $3.11B.
TMDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Weill David | director | Buy | 1,336 | $81.63 | $109.1K | 16,392 |
| Jun 17, 2026 | Gunderson Thomas J. | director | Sell | 9,624 | $75.06 | $722.4K | 16,642-37% |
| Mar 6, 2026 | Lovell Stephanie | director | Sell | 1,193 | $149.62 | $178.5K | 2,866-29% |
| Mar 6, 2026 | Weill David | director | Sell | 3,571 | $146.82 | $524.3K | 12,134 |
| Mar 5, 2025 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,407 | $76.43 | $184.0K | 36,042 |
| Jan 10, 2025 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,083 | $80.05 | $86.7K | 20,843 |
| Dec 4, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,084 | $86.40 | $93.7K | 20,843 |
| Nov 13, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,458 | $90.04 | $131.3K | 20,843 |
| Nov 7, 2024 | Basile Edward M | Sell | 6,750 | $83.55 | $564.0K | 2,186-76% | |
| Nov 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,083 | $82.64 | $89.5K | 20,843 |
| Oct 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $132.71 | $1.14M | 66,661 |
| Oct 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $148.24 | $438.5K | 22,978 |
| Sep 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $153.42 | $1.32M | 69,360 |
| Sep 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,960 | $159.60 | $472.4K | 23,204 |
| Aug 29, 2024 | Corcoran Nicholas | See Remarks | Sell | 10,000 | $176.02 | $1.76M | 21,105-32% |
| Aug 23, 2024 | Hassanein Waleed H | President & CEO | Sell | 45,000 | $173.24 | $7.80M | 61,643-42% |
| Aug 19, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $169.73 | $1.46M | 69,968 |
| Aug 9, 2024 | Ranganath Anil P. | See remarks | Sell | 4,992 | $149.81 | $747.8K | 8,893-36% |
| Aug 9, 2024 | TOBIN JAMES R | Sell | 20,000 | $159.33 | $3.19M | 180,482 | |
| Aug 8, 2024 | Basile Edward M | Sell | 6,750 | $149.96 | $1.01M | 5,652-54% | |
| Aug 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $156.77 | $463.7K | 23,687 |
| Jul 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $145.17 | $1.25M | 68,871 |
| Jul 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $151.40 | $447.9K | 23,691 |
| Jun 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $141.85 | $1.22M | 68,654 |
| Jun 7, 2024 | Basile Edward M | Sell | 1,193 | $138.08 | $164.7K | 732-62% | |
| Jun 5, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 2,060 | $135.93 | $280.0K | 21,299 |
| Jun 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,960 | $133.10 | $394.0K | 23,698 |
| May 31, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 20,000 | $141.40 | $2.83M | 29,954-40% |
| May 31, 2024 | Weill David | Sell | 1,193 | $141.65 | $169.0K | 10,732 | |
| May 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $135.32 | $1.17M | 69,968 |
| May 14, 2024 | Weill David | Sell | 2,500 | $129.82 | $324.6K | 11,193 | |
| May 8, 2024 | Basile Edward M | Sell | 7,157 | $129.98 | $930.3K | 6,220-54% | |
| May 8, 2024 | Corcoran Nicholas | See Remarks | Sell | 3,222 | $129.91 | $418.6K | 21,105 |
| May 8, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $128.00 | $1.92M | 23,299-39% |
| May 8, 2024 | Hassanein Waleed H | President & CEO | Sell | 30,000 | $130.07 | $3.90M | 61,643-33% |
| May 8, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 5,839 | $130.07 | $759.5K | 9,792-37% |
| May 7, 2024 | TOBIN JAMES R | Sell | 12,025 | $125.05 | $1.50M | 200,041 | |
| May 3, 2024 | Hassanein Waleed H | President & CEO | Sell | 68,444 | $116.68 | $7.99M | 127,402-35% |
| May 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 78,036 | $109.78 | $8.57M | 49,821-61% |
| May 3, 2024 | TOBIN JAMES R | Sell | 15,040 | $106.43 | $1.60M | 208,975 | |
| Apr 18, 2024 | Hassanein Waleed H | President & CEO | Sell | 4,000 | $95.12 | $380.5K | 74,087 |
| Apr 12, 2024 | Hassanein Waleed H | President & CEO | Sell | 12,000 | $95.09 | $1.14M | 74,087 |
| Apr 10, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 19,900 | $90.35 | $1.80M | 30,165-40% |
| Apr 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 10,000 | $80.21 | $802.1K | 25,185-28% |
| Apr 2, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $74.01 | $1.11M | 23,299-39% |
| Mar 12, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 1,903 | $87.63 | $166.8K | 23,299 |
| Mar 12, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,417 | $87.80 | $124.4K | 26,502 |
| Mar 5, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $82.80 | $1.24M | 25,202-37% |
| Mar 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 10,000 | $82.99 | $829.9K | 33,634 |
| Mar 5, 2024 | TOBIN JAMES R | Sell | 13,380 | $83.63 | $1.12M | 233,391 |
Showing 1–50 of 161
1 / 4
TMDX Insider Buying Activity
The following table shows recent insider purchases of TransMedics Group, Inc. (TMDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Weill David | director | Buy | 1,336 | $81.63 | $109.1K | 16,392 |
TMDX Insider Selling Activity
The following table shows recent insider sales of TransMedics Group, Inc. (TMDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Gunderson Thomas J. | director | Sell | 9,624 | $75.06 | $722.4K | 16,642-37% |
| Mar 6, 2026 | Lovell Stephanie | director | Sell | 1,193 | $149.62 | $178.5K | 2,866-29% |
| Mar 6, 2026 | Weill David | director | Sell | 3,571 | $146.82 | $524.3K | 12,134 |
| Mar 5, 2025 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,407 | $76.43 | $184.0K | 36,042 |
| Jan 10, 2025 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,083 | $80.05 | $86.7K | 20,843 |
| Dec 4, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,084 | $86.40 | $93.7K | 20,843 |
| Nov 13, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,458 | $90.04 | $131.3K | 20,843 |
| Nov 7, 2024 | Basile Edward M | Sell | 6,750 | $83.55 | $564.0K | 2,186-76% | |
| Nov 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,083 | $82.64 | $89.5K | 20,843 |
| Oct 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $132.71 | $1.14M | 66,661 |
| Oct 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $148.24 | $438.5K | 22,978 |
| Sep 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $153.42 | $1.32M | 69,360 |
| Sep 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,960 | $159.60 | $472.4K | 23,204 |
| Aug 29, 2024 | Corcoran Nicholas | See Remarks | Sell | 10,000 | $176.02 | $1.76M | 21,105-32% |
| Aug 23, 2024 | Hassanein Waleed H | President & CEO | Sell | 45,000 | $173.24 | $7.80M | 61,643-42% |
| Aug 19, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $169.73 | $1.46M | 69,968 |
| Aug 9, 2024 | Ranganath Anil P. | See remarks | Sell | 4,992 | $149.81 | $747.8K | 8,893-36% |
| Aug 9, 2024 | TOBIN JAMES R | Sell | 20,000 | $159.33 | $3.19M | 180,482 | |
| Aug 8, 2024 | Basile Edward M | Sell | 6,750 | $149.96 | $1.01M | 5,652-54% | |
| Aug 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $156.77 | $463.7K | 23,687 |
| Jul 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $145.17 | $1.25M | 68,871 |
| Jul 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,958 | $151.40 | $447.9K | 23,691 |
| Jun 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $141.85 | $1.22M | 68,654 |
| Jun 7, 2024 | Basile Edward M | Sell | 1,193 | $138.08 | $164.7K | 732-62% | |
| Jun 5, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 2,060 | $135.93 | $280.0K | 21,299 |
| Jun 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 2,960 | $133.10 | $394.0K | 23,698 |
| May 31, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 20,000 | $141.40 | $2.83M | 29,954-40% |
| May 31, 2024 | Weill David | Sell | 1,193 | $141.65 | $169.0K | 10,732 | |
| May 17, 2024 | Hassanein Waleed H | President & CEO | Sell | 8,625 | $135.32 | $1.17M | 69,968 |
| May 14, 2024 | Weill David | Sell | 2,500 | $129.82 | $324.6K | 11,193 | |
| May 8, 2024 | Basile Edward M | Sell | 7,157 | $129.98 | $930.3K | 6,220-54% | |
| May 8, 2024 | Corcoran Nicholas | See Remarks | Sell | 3,222 | $129.91 | $418.6K | 21,105 |
| May 8, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $128.00 | $1.92M | 23,299-39% |
| May 8, 2024 | Hassanein Waleed H | President & CEO | Sell | 30,000 | $130.07 | $3.90M | 61,643-33% |
| May 8, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 5,839 | $130.07 | $759.5K | 9,792-37% |
| May 7, 2024 | TOBIN JAMES R | Sell | 12,025 | $125.05 | $1.50M | 200,041 | |
| May 3, 2024 | Hassanein Waleed H | President & CEO | Sell | 68,444 | $116.68 | $7.99M | 127,402-35% |
| May 3, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 78,036 | $109.78 | $8.57M | 49,821-61% |
| May 3, 2024 | TOBIN JAMES R | Sell | 15,040 | $106.43 | $1.60M | 208,975 | |
| Apr 18, 2024 | Hassanein Waleed H | President & CEO | Sell | 4,000 | $95.12 | $380.5K | 74,087 |
| Apr 12, 2024 | Hassanein Waleed H | President & CEO | Sell | 12,000 | $95.09 | $1.14M | 74,087 |
| Apr 10, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 19,900 | $90.35 | $1.80M | 30,165-40% |
| Apr 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 10,000 | $80.21 | $802.1K | 25,185-28% |
| Apr 2, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $74.01 | $1.11M | 23,299-39% |
| Mar 12, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 1,903 | $87.63 | $166.8K | 23,299 |
| Mar 12, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 1,417 | $87.80 | $124.4K | 26,502 |
| Mar 5, 2024 | Gordon Stephen | Chief Financial Officer | Sell | 15,000 | $82.80 | $1.24M | 25,202-37% |
| Mar 5, 2024 | Khayal Tamer I | Chief Commercial Officer | Sell | 10,000 | $82.99 | $829.9K | 33,634 |
| Mar 5, 2024 | TOBIN JAMES R | Sell | 13,380 | $83.63 | $1.12M | 233,391 |
TMDX Insiders
Similar Stocks to TMDX
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B